the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Market Research Report

Belgium Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012

Published by Global Markets Direct Contact us : +1-860-674-8796
Published 2009/01 Content info Pages: 123
Product code LABD80202
Price From  US $ 3000 Order/Price list
US $ 3000 PDF by E-mail (Single User License)
US $ 6000 PDF By E-mail (Site license)
US $ 9000 PDF By E-mail (Global Site License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
3 Definitions of the Markets Covered in the Report 13
3.1 Neurology Devices 13
3.2 CSF (Cerebro Spinal Fluid) Management 13
3.2.1 Hydrocephalus shunt 13
3.2.2 Intra Cranial Pressure (ICP) Monitors 13
3.3 Interventional Neurology 13
3.3.1 Aneurysm Clips 13
3.3.2 Embolic System 13
3.3.3 Navigational System 14
3.4 Neurostimulation Device 14
3.4.1 Spinal Cord Stimulator (SCS) 14
3.4.2 Deep Brain Stimulator (DBS) 14
3.4.3 Vagus Nerve stimulation (VNS) 14
3.5 Neurosurgical Products (Neuroendoscopes) 15
3.5.1 Neuroendoscopes 15
3.6 Radio surgery 15
3.6.1 Cyber Knife Radiosurgery 15
3.6.2 Gamma Knife Radiosurgery 15
4 Healthcare Sector Review 16
4.1 Healthcare Expenditure 16
4.2 Healthcare Infrastructure 18
4.2.1 Healthcare Personnel Data 19
4.2.2 Healthcare Facilities Data 20
4.3 Healthcare Policy 21
5 Regulation System 23
5.1 Medical Equipment Approval Process 23
5.1.1 Classification 24
5.1.2 Conformity Assessment Process 33
5.2 Notification Fee 37
6 Pricing and Reimbursement 38
6.1 Reimbursement Policies 38
7 Distribution Structure 39
8 Neurology Devices In Belgium 40
8.1 Neurology Devices Cross Country Comparison (2000-2012) 40
8.2 Neurology Devices, Belgium, Overall Revenues ($ mn), 2000-2012 41
8.3 Neurology Devices, Belgium, Category Volume (Units), 2000-2012 45
8.4 Neurology Devices, Belgium, Company Share (2006-2007) 47
9 CSF Management In Belgium 48
9.1 CSF Management Overall Revenue (2000-2012) 48
9.2 CSF Management Overall Volume (2000-2012) 50
9.3 CSF Management Average Price (2000-2012) 52
9.4 CSF Management Distribution Share (2006-2007) 53
9.5 CSF Management, Belgium, Company Share (2006-2007) 54
10 Interventional Neurology In Belgium 55
10.1 Interventional Neurology Overall Revenue (2000-2012) 55
10.1.1 Embolic Systems Overall Revenues (2000-2012) 57
10.1.2 Navigational Systems Overall Revenues (2000-2012) 59
10.2 Interventional Neurology Overall Volume (2000-2012) 61
10.2.1 Embolic Systems Overall Volume (2000-2012) 63
10.2.2 Navigational Systems Overall Volume (2000-2012) 65
10.3 Interventional Neurology Average Price (2000-2012) 67
10.4 Interventional Neurology Distribution Share (2006-2007) 68
10.5 Interventional Neurology, Belgium, Company Share (2006-2007) 69
11 Neurostimulation Devices In Belgium 70
11.1 Neurostimulation Devices Overall Revenue (2000-2012) 70
11.2 Neurostimulation Devices Overall Volume (2000-2012) 72
11.3 Neurostimulation Devices Average Price (2000-2012) 74
11.4 Neurostimulation Devices Distribution Share (2006-2007) 75
11.5 Neurostimulation Devices, Belgium, Company Share (2006-2007) 76
12 Neurosurgical Products (Neuroendoscopes) Products In Belgium 77
12.1 Neurosurgical Products (Neuroendoscopes) Overall Revenue (2000-2012) 77
12.2 Neurosurgical Products (Neuroendoscopes) Overall Volume (2000-2012) 79
12.3 Neurosurgical Products (Neuroendoscopes) Average Price (2000-2012) 81
12.4 Neurosurgical Products (Neuroendoscopes) Distribution Share (2006-2007) 82
12.5 Neurosurgical Products (Neuroendoscopes), Belgium, Company Share (2006-2007) 83
13 Radiosurgery In Belgium 84
13.1 Radiosurgery Overall Revenue (2000-2012) 84
13.2 Radiosurgery Overall Volume (2000-2012) 86
13.3 Radiosurgery Average Price (2000-2012) 88
13.4 Radiosurgery Distribution Share (2006-2007) 89
14 Elekta AB Company Profile 90
14.1 Company Overview 90
14.2 Value Chain Analysis 90
14.2.1 Manufacturing 91
14.2.2 Product Development 91
14.2.3 Sales and Marketing 91
14.2.4 Elekta AB Pipeline Products by Equipment Type 92
14.2.5 Elekta AB Pipeline Products by Development Stage 92
14.2.6 Elekta AB Pipeline Products by Therapy Area 92
14.2.7 Elekta AB Pipeline Products by News Summary 92
15 Medtronic, Inc. Company Profile 93
15.1 Company Overview 93
15.2 Value Chain Analysis 93
15.2.1 Manufacturing 94
15.2.2 Product Development 94
15.2.3 Sales and Marketing 94
15.3 Medtronic, Inc. Pipeline Products 95
15.3.1 Medtronic, Inc. Pipeline Products by Equipment Type 95
15.3.2 Medtronic, Inc. Pipeline Products by Development Stage 97
15.3.3 Medtronic, Inc. Pipeline Products by Therapy Area 99
15.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials 101
15.3.5 Medtronic, Inc. Pipeline Products by News Summary 102
16 Cyberonics, Inc. Company Profile 103
16.1 Company Overview 103
16.1.1 Cyberonics, Inc. Pipeline Products by Equipment Type 104
16.1.2 Cyberonics, Inc. Pipeline Products by Development Stage 104
16.1.3 Cyberonics, Inc. Pipeline Products by Therapy Area 104
17 Boston Scientific Corporation Company Profile 105
17.1 Company Overview 105
17.2 Value Chain Analysis 105
17.2.1 Manufacturing 106
17.2.2 Product Development 106
17.2.3 Sales and Marketing 107
17.3 Boston Scientific Corporation Pipeline Products 108
17.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type 108
17.3.2 Boston Scientific Corporation Pipeline Products by Development Stage 109
17.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area 110
17.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials 111
17.3.5 Boston Scientific Corporation Pipeline Products by News Summary 112
18 Cordis Corporation Company Profile 114
18.1 Company Overview 114
18.2 Cordis Corporation Pipeline Products 115
18.2.1 Cordis Corporation Pipeline Products by Equipment Type 115
18.2.2 Cordis Corporation Pipeline Products by Development Stage 115
18.2.3 Cordis Corporation Pipeline Products by Therapy Area 116
18.2.4 Cordis Corporation Pipeline Products by Clinical Trials 116
18.2.5 Cordis Corporation Pipeline Products by News Summary 116
19 Advanced Neuromodulation Systems, Inc. Company Profile 117
19.1 Company Overview 117
20 Appendix 118
20.1 Global Markets Direct Research Methodology 118
20.2 Coverage 119
20.3 Secondary Research 119
20.4 Primary Research 120
20.5 Models 120
20.6 Forecasts 121
20.7 Expert Panels 121
20.8 Currency Conversion 122
20.9 Contact Us 123
20.10 Disclaimer 123

1.1 List of Tables
Table 1: Hospitals and Hospital Beds in Belgium, 2005 18
Table 2: Number of Doctors by Specialty in Belgium, 2003-2007 19
Table 3: Number of Hospital Wards by Specialty in Belgium, 2003-2007 20
Table 4: Medical Equipment Notification Fee in Belgium, 2007 37
Table 5: Neurology Devices Cross Country Comparison (2000-2012) 40
Table 6: Neurology Devices, Belgium, Overall Revenues ($ mn), 2000-2012 41
Table 7: Neurology Devices, Belgium, Portfolio Analysis, 2000-2012 42
Table 8: Neurology Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007 43
Table 9: Neurology Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 44
Table 10: Neurology Devices, Belgium, Category Volume (Units), 2000-2012 45
Table 11: Neurology Devices, Belgium, Category Volume (Units), Historic, 2000-2007 46
Table 12: Neurology Devices, Belgium, Category Volume (Units), Forecast, 2007-2012 46
Table 13: Neurology Devices, Belgium, Company Share by Revenue ($ mn), 2006-2007 47
Table 14: CSF Management, Belgium, Revenue ($ mn), Historic, 2000-2007 48
Table 15: CSF Management, Belgium, Revenue ($ mn), Forecast, 2007-2012 49
Table 16: CSF Management, Belgium, Overall Volume (Units), Historic, 2000-2007 50
Table 17: CSF Management, Belgium, Overall Volume (Units), Forecast, 2007-2012 51
Table 18: CSF Management, Belgium, Average Price ($), Historic, 2000-2007 52
Table 19: CSF Management, Belgium, Average Price ($), Forecast, 2007-2012 52
Table 20: CSF Management, Belgium, Distribution Share by Revenue ($mn), 2006-2007 53
Table 21: CSF Management, Belgium, Company Share by Revenue ($ mn), 2006-2007 54
Table 22: Interventional Neurology, Belgium, Revenue ($ mn), Historic, 2000-2007 55
Table 23: Interventional Neurology, Belgium, Revenue ($ mn), Forecast, 2007-2012 56
Table 24: Embolic Systems, Belgium, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 57
Table 25: Embolic Systems, Belgium, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 58
Table 26: Navigational Systems, Belgium, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 59
Table 27: Navigational Systems, Belgium, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 60
Table 28: Interventional Neurology, Belgium, Overall Volume (Units), Historic, 2000-2007 61
Table 29: Interventional Neurology, Belgium, Overall Volume (Units), Forecast, 2007-2012 62
Table 30: Embolic Systems, Belgium, Volume (Units) by Sub-Segment, Historic, 2000-2007 63
Table 31: Embolic Systems, Belgium, Volume (Units) by Sub-Segment, Forecast, 2007-2012 64
Table 32: Navigational Systems, Belgium, Volume (Units) by Sub-Segment, Historic, 2000-2007 65
Table 33: Navigational Systems, Belgium, Volume (Units) by Sub-Segment, Forecast, 2007-2012 66
Table 34: Interventional Neurology, Belgium, Average Price ($), Historic, 2000-2007 67
Table 35: Interventional Neurology, Belgium, Average Price ($), Forecast, 2007-2012 67
Table 36: Interventional Neurology, Belgium, Distribution Share by Revenue ($mn), 2006-2007 68
Table 37: Interventional Neurology, Belgium, Company Share by Revenue ($ mn), 2006-2007 69
Table 38: Neurostimulation Devices, Belgium, Revenue ($ mn), Historic, 2000-2007 70
Table 39: Neurostimulation Devices, Belgium, Revenue ($ mn), Forecast, 2007-2012 71
Table 40: Neurostimulation Devices, Belgium, Overall Volume (Units), Historic, 2000-2007 72
Table 41: Neurostimulation Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012 73
Table 42: Neurostimulation Devices, Belgium, Average Price ($), Historic, 2000-2007 74
Table 43: Neurostimulation Devices, Belgium, Average Price ($), Forecast, 2007-2012 74
Table 44: Neurostimulation Devices, Belgium, Distribution Share by Revenue ($mn), 2006-2007 75
Table 45: Neurostimulation Devices, Belgium, Company Share by Revenue ($ mn), 2006-2007 76
Table 46: Neurosurgical Products (Neuroendoscopes), Belgium, Revenue ($ mn), Historic, 2000-2007 77
Table 47: Neurosurgical Products (Neuroendoscopes), Belgium, Revenue ($ mn, Forecast, 2007-2012 78
Table 48: Neurosurgical Products (Neuroendoscopes), Belgium, Overall Volume (Units), Historic, 2000-2007 79
Table 49: Neurosurgical Products (Neuroendoscopes), Belgium, Overall Volume (Units), Forecast, 2007-2012 80
Table 50: Neurosurgical Products (Neuroendoscopes), Belgium, Average Price ($), Historic, 2000-2007 81
Table 51: Neurosurgical Products (Neuroendoscopes), Belgium, Average Price ($), Forecast, 2007-2012 81
Table 52: Neurosurgical Products (Neuroendoscopes), Belgium, Distribution Share by Revenue ($mn), 2006-2007 82
Table 53: Neurosurgical Products (Neuroendoscopes), Belgium, Company Share by Revenue ($ mn), 2006-2007 83
Table 54: Radiosurgery, Belgium, Revenue ($ mn), Historic, 2000-2007 84
Table 55: Radiosurgery, Belgium, Revenue ($ mn), Forecast, 2007-2012 85
Table 56: Radiosurgery, Belgium, Overall Volume (Units), Historic, 2000-2007 86
Table 57: Radiosurgery, Belgium, Overall Volume (Units), Forecast, 2007-2012 87
Table 58: Radiosurgery, Belgium, Average Price ($), Historic, 2000-2007 88
Table 59: Radiosurgery, Belgium, Average Price ($), Forecast, 2007-2012 88
Table 60: Radiosurgery, Belgium, Distribution Share by Revenue ($mn), 2006-2007 89
Table 61: Elekta AB Pipeline Products by Equipment Type 92
Table 62: Elekta AB Pipeline Products By Development Stage 92
Table 63: Elekta AB Pipeline Products By Therapy Area 92
Table 64: Elekta AB Pipeline Products By News Summaries 92
Table 65: Medtronic, Inc. Pipeline Products by Equipment Type 95
Table 66: Medtronic, Inc. Pipeline Products By Development Stage 97
Table 67: Medtronic, Inc. Pipeline Products By Therapy Area 99
Table 68: Medtronic, Inc. Pipeline Products By Clinical Trials 101
Table 69: Medtronic, Inc. Pipeline Products By News Summaries 102
Table 70: Cyberonics, Inc. Pipeline Products by Equipment Type 104
Table 71: Cyberonics, Inc. Pipeline Products By Development Stage 104
Table 72: Cyberonics, Inc. Pipeline Products By Therapy Area 104
Table 73: Boston Scientific Corporation Pipeline Products by Equipment Type 108
Table 74: Boston Scientific Corporation Pipeline Products By Development Stage 109
Table 75: Boston Scientific Corporation Pipeline Products By Therapy Area 110
Table 76: Boston Scientific Corporation Pipeline Products By Clinical Trials 111
Table 77: Boston Scientific Corporation Pipeline Products By News Summaries 112
Table 78: Cordis Corporation Pipeline Products by Equipment Type 115
Table 79: Cordis Corporation Pipeline Products By Development Stage 115
Table 80: Cordis Corporation Pipeline Products By Therapy Area 116
Table 81: Cordis Corporation Pipeline Products By Clinical Trials 116
Table 82: Cordis Corporation Pipeline Products By News Summaries 116
Table 83: Currency Conversion from USD to Local Currency at 2007 Constant Rate 122

1.2 List of Figures
Figure 1: Total Healthcare Expenditure in Belgium, 2000 - 2006 17
Figure 2: Structure of Healthcare System in Belgium, 2007 22
Figure 3: Flowchart for Classification of Non-invasive Devices in Belgium, 2007 25
Figure 4: Flowchart for Classification of Invasive Devices in Belgium, 2007 26
Figure 5: Flowchart for Classification of Invasive Devices in Belgium, 2007 27
Figure 6: Flowchart for Classification of Invasive Devices in Belgium, 2007 28
Figure 7: Flowchart for Classification of Invasive Devices in Belgium, 2007 29
Figure 8: Flowchart for Classification of Active Devices in Belgium, 2007 30
Figure 9: Flowchart for Classification of Active Devices in Belgium, 2007 31
Figure 10: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Belgium, 2007 32
Figure 11: Conformity Assessment of Class-I Medical Devices in Belgium, 2007 33
Figure 12: Conformity Assessment of Class-IIa Medical Devices in Belgium, 2007 34
Figure 13: Conformity Assessment of Class-IIb Medical Devices in Belgium, 2007 35
Figure 14: Conformity Assessment of Class-III Medical Devices in Belgium, 2007 36
Figure 15: Neurology Devices Cross Country Comparison (2000-2012) 40
Figure 16: Neurology Devices, Belgium, Overall Revenues ($ mn), 2000-2012 41
Figure 17: Neurology Devices, Belgium, Portfolio Analysis, 2000-2012 42
Figure 18: Neurology Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 44
Figure 19: Neurology Devices, Belgium, Company Share (%), 2007 47
Figure 20: CSF Management, Belgium, Revenue ($ mn), Historic, 2000-2007 48
Figure 21: CSF Management, Belgium, Revenue ($ mn), Forecast, 2007-2012 49
Figure 22: CSF Management, Belgium, Overall Volume (Units), Historic, 2000-2007 50
Figure 23: CSF Management, Belgium, Overall Volume (Units), Forecast, 2007-2012 51
Figure 24: CSF Management, Belgium, Company Share (%), 2007 54
Figure 25: Interventional Neurology, Belgium, Revenue ($ mn), Historic, 2000-2007 55
Figure 26: Interventional Neurology, Belgium, Revenue ($ mn), Forecast, 2007-2012 56
Figure 27: Embolic Systems, Belgium, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 57
Figure 28: Embolic Systems, Belgium, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 58
Figure 29: Navigational Systems, Belgium, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 59
Figure 30: Navigational Systems, Belgium, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 60
Figure 31: Interventional Neurology, Belgium, Overall Volume (Units), Historic, 2000-2007 61
Figure 32: Interventional Neurology, Belgium, Overall Volume (Units), Forecast, 2007-2012 62
Figure 33: Embolic Systems, Belgium, Volume (Units) by Sub-Segment, Historic, 2000-2007 63
Figure 34: Embolic Systems, Belgium, Volume (Units) by Sub-Segment, Forecast, 2007-2012 64
Figure 35: Navigational Systems, Belgium, Volume (Units) by Sub-Segment, Historic, 2000-2007 65
Figure 36: Navigational Systems, Belgium, Volume (Units) by Sub-Segment, Forecast, 2007-2012 66
Figure 37: Interventional Neurology, Belgium, Company Share (%), 2007 69
Figure 38: Neurostimulation Devices, Belgium, Revenue ($ mn), Historic, 2000-2007 70
Figure 39: Neurostimulation Devices, Belgium, Revenue ($ mn), Forecast, 2007-2012 71
Figure 40: Neurostimulation Devices, Belgium, Overall Volume (Units), Historic, 2000-2007 72
Figure 41: Neurostimulation Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012 73
Figure 42: Neurostimulation Devices, Belgium, Company Share (%), 2007 76
Figure 43: Neurosurgical Products (Neuroendoscopes), Belgium, Revenue ($ mn), Historic, 2000-2007 77
Figure 44: Neurosurgical Products (Neuroendoscopes), Belgium, Revenue ($ mn), Forecast, 2007-2012 78
Figure 45: Neurosurgical Products (Neuroendoscopes), Belgium, Overall Volume (Units), Historic, 2000-2007 79
Figure 46: Neurosurgical Products (Neuroendoscopes), Belgium, Overall Volume (Units), Forecast, 2007-2012 80
Figure 47: Neurosurgical Products (Neuroendoscopes), Belgium, Company Share (%), 2007 83
Figure 48: Radiosurgery, Belgium, Revenue ($ mn), Historic, 2000-2007 84
Figure 49: Radiosurgery, Belgium, Revenue ($ mn), Forecast, 2007-2012 85
Figure 50: Radiosurgery, Belgium, Overall Volume (Units), Historic, 2000-2007 86
Figure 51: Radiosurgery, Belgium, Overall Volume (Units), Forecast, 2007-2012 87
Figure 52: Elekta AB Value Chain Analysis 90
Figure 53: Medtronic, Inc. Value Chain Analysis 93
Figure 54: Boston Scientific Corporation Value Chain Analysis 105
Figure 55: Global Markets Direct Methodology 118

Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.